Your browser doesn't support javascript.
loading
Melanoma Brain Metastasis: Biology and Therapeutic Advances.
Hasanov, Merve; Acikgoz, Yusuf; Davies, Michael A.
Afiliación
  • Hasanov M; Division of Medical Oncology, Department of Internal Medicine, The Ohio State University Comprehensive Cancer Center, Suite 1335, Lincoln Tower, 1800 Cannon Drive, Columbus, OH, 43210, USA. Electronic address: merve.hasanov@osumc.edu.
  • Acikgoz Y; Division of Medical Oncology, Department of Internal Medicine, The Ohio State University Comprehensive Cancer Center, 13th floor, Lincoln Tower, 1800 Cannon Drive, Columbus, OH, 43210, USA.
  • Davies MA; Division of Cancer Medicine, Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Boulevard, Unit 0430, Houston, TX 77030, USA.
Hematol Oncol Clin North Am ; 38(5): 1027-1043, 2024 10.
Article en En | MEDLINE | ID: mdl-38845301
ABSTRACT
Metastasis to the brain is a frequent complication of advanced melanoma. Historically, patients with melanoma brain metastasis (MBM) have had dismal outcomes, but outcomes have improved with the development of more effective treatments, including stereotactic radiosurgery and effective immune and targeted therapies. Despite these advances, MBM remains a leading cause of death from this disease, and many therapies show decreased efficacy against these tumors compared with extracranial metastases. This differential efficacy may be because of recently revealed unique molecular and immune features of MBMs-which may also provide rational new therapeutic strategies.
Asunto(s)
Palabras clave

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Neoplasias Encefálicas / Melanoma Límite: Humans Idioma: En Año: 2024 Tipo del documento: Article

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Neoplasias Encefálicas / Melanoma Límite: Humans Idioma: En Año: 2024 Tipo del documento: Article